MacTel_cohort_Omni5_genotypes

MacTel SNP chip data access policy

Macular Telangiectasia type 2 (MacTel) is a rare neurodegenerative retinal eye disease. The mission of the Lowy Medical Research Institute (LMRI) is to identify the etiology of MacTel and develop therapies to treat the disease. The MacTel Project, which is overseen by the Lowy Medical Research Institute, carefully screens individuals to confirm the diagnosis of MacTel and collects blood samples from individuals enrolling in the MacTel registry. These blood samples are used to study the genetic basis of the disease, and are the sample source for this dataset. The use of these data is restricted to studies on Macular Telangiectasia type 2, and studies must be approved by the LMRI Data Access Committee. Data available: Approximately 700 samples with genotypes from the Illumina Omni5 SNP array. To apply for access to the LMRI dataset, please contact lscheppke@lmri.net.